Specialties

June 13, 2025

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

Neoadjuvant nivolumab plus chemotherapy significantly improved overall survival rates at 5 years compared with chemotherapy before surgery alone in patients with resectable non–small cell lung cancer ...

The ASCO Post

June 13, 2025

Breast Cancer Radiotherapy Leads to Moderate Cardiac Function Decline Over Years

The ASCO Post

June 13, 2025

Prophylactic Radiation Therapy of the Contralateral Breast in BRCA Carriers with Early-Stage Breast Cancer

The ASCO Post

June 13, 2025

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

The ASCO Post

June 13, 2025

Navigational Bronchoscopy vs Transthoracic Needle Biopsy for Lung Nodules: Diagnostic Accuracy

The ASCO Post

June 12, 2025

Cellular Therapies Show Sustained Promise in Hematologic Malignancies, but Access Remains Uneven

The ASCO Post

Latest Headlines

June 13, 2025

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

The ASCO Post

June 13, 2025

Breast Cancer Radiotherapy Leads to Moderate Cardiac Function Decline Over Years

The ASCO Post

June 13, 2025

Prophylactic Radiation Therapy of the Contralateral Breast in BRCA Carriers with Early-Stage Breast Cancer

The ASCO Post

June 13, 2025

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

The ASCO Post

June 13, 2025

Navigational Bronchoscopy vs Transthoracic Needle Biopsy for Lung Nodules: Diagnostic Accuracy

The ASCO Post

June 12, 2025

Cellular Therapies Show Sustained Promise in Hematologic Malignancies, but Access Remains Uneven

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

2025 ASCO Annual Meeting

June 13, 2025

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

The ASCO Post

June 13, 2025

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

The ASCO Post

June 10, 2025

Study Shows Potential Benefits of AI-Assisted Classification in HER2-Low and HER2-Ultralow Breast Cancer

The ASCO Post

EULAR 2025 - Congress

June 13, 2025

JAK Inhibitors Show No Increased Cancer Risk

Conexiant

June 06, 2025

New Global Criteria Define Pediatric Bone Disease

Conexiant

SGO 2025 Annual Meeting on Womens Cancer

June 11, 2025

Evolving Role of Surgical De-escalation for Endometrial, Ovarian, Cervical, and Vulvar Cancers

The ASCO Post

May 22, 2025

Quick Takes on Research Findings on Novel Therapies for Gynecologic Cancers

The ASCO Post

May 22, 2025

Combination Therapy for Newly Diagnosed, BRCA-Nonmutated, Advanced Epithelial Ovarian Cancer

The ASCO Post

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Specialties

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

Breast Cancer Radiotherapy Leads to Moderate Cardiac Function Decline Over Years

Prophylactic Radiation Therapy of the Contralateral Breast in BRCA Carriers with Early-Stage Breast Cancer

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

Navigational Bronchoscopy vs Transthoracic Needle Biopsy for Lung Nodules: Diagnostic Accuracy

Cellular Therapies Show Sustained Promise in Hematologic Malignancies, but Access Remains Uneven

Latest Headlines

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

Breast Cancer Radiotherapy Leads to Moderate Cardiac Function Decline Over Years

Prophylactic Radiation Therapy of the Contralateral Breast in BRCA Carriers with Early-Stage Breast Cancer

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

Navigational Bronchoscopy vs Transthoracic Needle Biopsy for Lung Nodules: Diagnostic Accuracy

Cellular Therapies Show Sustained Promise in Hematologic Malignancies, but Access Remains Uneven

Daily News

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Conference Coverage

2025 ASCO Annual Meeting

Neoadjuvant Nivolumab and Chemotherapy Shows Significant OS Benefit at 5 Years in Resectable NSCLC

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

Study Shows Potential Benefits of AI-Assisted Classification in HER2-Low and HER2-Ultralow Breast Cancer

EULAR 2025 - Congress

JAK Inhibitors Show No Increased Cancer Risk

New Global Criteria Define Pediatric Bone Disease

SGO 2025 Annual Meeting on Womens Cancer

Evolving Role of Surgical De-escalation for Endometrial, Ovarian, Cervical, and Vulvar Cancers

Quick Takes on Research Findings on Novel Therapies for Gynecologic Cancers

Combination Therapy for Newly Diagnosed, BRCA-Nonmutated, Advanced Epithelial Ovarian Cancer

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Reuters

Specialties

SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC

Navigational Bronchoscopy vs Transthoracic Needle Biopsy for Lung Nodules: Diagnostic Accuracy

Cellular Therapies Show Sustained Promise in Hematologic Malignancies, but Access Remains Uneven

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Conference Coverage

2025 ASCO Annual Meeting

EULAR 2025 - Congress

SGO 2025 Annual Meeting on Womens Cancer